Table 2.
Current symptoms, medication and behavior according to history of self-harm behavior
| |
Overall n = 251a |
Suicide attempt n = 88 |
No suicide attempt |
Statistics (DF) |
Post hoce |
|
|---|---|---|---|---|---|---|
|
Group 1 |
Group 2 |
Group 3 |
||||
|
SA + NSSH |
SA only |
NoSA n = 163 |
||||
| n = 36 | n = 52 | |||||
| Global Assessment of Functioning, mean (SD) |
41.7 (10.3) |
37.4 (7.4) |
41.6 (8.9) |
42.6 (11.0) |
F = 3.9 (2, 250)**b |
1 < 3 |
| PANSS |
|
|
|
|
|
|
| Total, mean (SD) |
67.2 (17.6) |
72.0 (15.3) |
66.3 (17.2) |
66.3 (18.1) |
F = 1.6 (2, 247)nsb |
|
| Positive symptoms, mean (SD) |
16.3 (5.4) |
17.9 (4.1) |
16.6 (5.5) |
15.8 (5.5) |
F = 2.5 (2, 250)nsb |
|
| - PANSS P1 Delusions |
3.6 (1.4) |
4.1 (1.2) |
3.6 (1.2) |
3.4 (1.5) |
F = 3.7 (2, 249) *b |
1 > 3 |
| - PANSS P3 Hallucinatory behavior |
3.0 (1.7) |
3.9 (1.5) |
2.9 (1.5) |
2.8 (1.7) |
F = 7.0 (2, 249) **b |
1 > 2, 3 |
| Negative symptoms, mean (SD) |
16.7 (6.6) |
15.8 (6.4) |
15.6 (5.9) |
17.2 (6.8) |
F = 1.5 (2, 249)nsb |
|
| CDSS (current depression) suicide item excludedc, mean (SD) |
5.6 (4.7) |
9.5 (5.0) |
6.0 (4.6) |
4.6 (4.2) |
F = 18.2 (2, 241) ***b |
1 > 2, 3 |
| PANSS G14 (Impulsive aggression), median (min-max) |
1 (1–6) |
2 (1–6) |
1 (1–4) |
1 (1–4) |
K = 24.1 (2)***c |
1 > 2, 3 |
| InterSePT 5 (Current suicidality) |
|
|
|
|
χ2 = 30.4 (4)***d |
|
| - No current suicidality (0), n (%) |
157 (63) |
13 (36) |
27 (53) |
117 (72) |
|
|
| - Low suicidality (0.1-1.0), n (%) |
75 (30) |
14 (39) |
20 (39) |
41 (25) |
|
|
| - Moderate to high (1.1-2.0), n (%) |
18 (7) |
9 (25) |
4 (8) |
5 (3) |
|
1 > 2, 3f |
| Alcohol abuse or addiction last 6 months, n (%) |
16 (7) |
2 (6) |
6 (12) |
8 (5) |
χ2 = 2.9 (2)nsd |
|
| Substance abuse or addiction last 6 months, n (%) |
23 (9) |
4 (11) |
5 (10) |
14 (9) |
χ2 =0.2 (2)nsd |
|
| Current medication: |
|
|
|
|
X2 = 10.9 (4) *d |
|
| - No antipsychotic medication, n (%) |
44 (18) |
12 (33) |
11 (21) |
21 (13) |
|
1 ≠ 3g |
| - Antipsychotic, no antidepressant, n (%) |
150 (60) |
16 (44) |
27 (52) |
107 (66) |
|
|
| - Antipsychotic and antidepressant, n (%) | 57 (23) | 8 (22) | 14 (27) | 35 (22) | ||
Levels of statistical significance: ns = not significant * = p < 0.05, ** = p < 0.01, *** = p < 0.001.
aData missing for 0–9 patients, percentages based on valid observations, bF = One-way ANOVA test, cK = Kruskal-Wallis test, dχ2 = Pearson chi square test, ePlanned pairwise comparisons of Group 1 (SA + NSSH) vs Group 2 (SA only) and Group 1 (SA + NSSH) vs Group 3 (NoSA) (Scheffe’s test, Pearson chi square test, Mann–Whitney U test). Only statistically significant differences (p < .05) presented. f Comparing those scoring moderate to high with those with low/no current suicidality, g Comparing those with no antipsychotic medication to those with antipsychotic medication (with/without antidepressant medication).